Medtronic plc (MDT)
| Market Cap | 125.38B |
| Revenue (ttm) | 35.48B |
| Net Income (ttm) | 4.61B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.58 |
| PE Ratio | 27.28 |
| Forward PE | 16.41 |
| Dividend | $2.84 (2.93%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 8,321,577 |
| Open | 96.69 |
| Previous Close | 97.03 |
| Day's Range | 96.30 - 98.06 |
| 52-Week Range | 79.55 - 106.33 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 109.82 (+12.45%) |
| Earnings Date | Feb 17, 2026 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $109.82, which is an increase of 12.45% from the latest price.
News
Best Dividend Aristocrats For March 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY...
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor
Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global lead...
MiniMed announces launch of IPO roadshow
GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial pub...
Medtronic's MiniMed aims to raise $784 million in US IPO
Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.
Medtronic Analysts Cut Their Forecasts After Q3 Earnings
Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday.
Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth
Adjusted earnings of $1.36 per share also beat expectations of $1.33.
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
Medtronic plc (MDT) Q3 2026 Earnings Call Transcript
Medtronic Profit Falls Despite Higher Revenue
Medtronic said profit fell in its fiscal third quarter as costs rose and the company invested more money into the business, offsetting higher revenue.
Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling.
Medtronic says it expects to take a $185 million hit from tariffs in the fiscal year.
Medtronic beats quarterly profit estimates on robust demand for heart devices
Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand for its heart devices and diabetes monitors.
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters
Cardiovascular portfolio up 11% year-over-year; Cardiac Ablation Solutions grew 80% on strength of pulsed field ablation portfolio GALWAY, Ireland, Feb. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: M...
Medtronic announces first surgery with Hugo™ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic
Newly FDA-cleared system helps expand patient access to minimally invasive surgery Cleveland Clinic joins nationally recognized academic medical centers including Atrium Health Wake Forest Baptist Hig...
Medtronic: Navigating Tariffs And Chinese VBP Challenges
Medtronic delivered solid Q2 results with beats on revenue and EPS, but now trades at a 5% premium to fair value. Segment growth was led by Cardiovascular and Diabetes, though headwinds from Chinese p...
Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ s...
How To Earn $500 A Month From Medtronic Stock Ahead Of Q3 Earnings
Medtronic plc (NYSE: MDT) will release earnings for its third quarter before the opening bell on Tuesday, Feb. 17.
Medtronic to announce financial results for its third quarter of fiscal year 2026
GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026,...
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic
RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical Prevails in Antitrust Jury Trial Against Medtronic.
Medtronic owes $382 million to medical device rival in antitrust lawsuit, US jury says
Medical technology company Medtronic owes rival device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel sealing surgical devices, ...
Medical device maker Medtronic to buy CathWorks in up to $585 million deal
Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could im...
Medtronic advances its innovation strategy with intent to acquire CathWorks
Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology p...
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexib...
Final Trades: Capital One, Medtronic, Transocean and Caterpillar
The Investment Committee give you their top stocks to watch for the second half.
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first...
Medtronic: Don't Miss Out On This Dividend Aristocrat Now
Medtronic is months away from upping its quarterly dividend per share for the 48th consecutive year. The medtech company's outsized demand for the Pulsed Field Ablation and Symplicity hypertension fra...